Free Trial

Seelos Therapeutics (SEEL) SEC Filings & 10K Form

Seelos Therapeutics logo
$0.27 -0.02 (-8.03%)
(As of 12/20/2024 ET)

Recent Seelos Therapeutics SEC Filings

DateFilerForm TypeView
12/04/2024
12:29 PM
AdvisorShares Trust (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
Seelos Therapeutics (Subject)
Form SC 13G/A
11/25/2024
2:37 PM
SEELOS THERAPEUTICS, INC. (Subject)
Seelos Therapeutics (Subject)
Weber Mark (Filed by)
Form SCHEDULE 13G
11/22/2024
7:35 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
7:36 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form NT 10-Q
11/14/2024
6:32 PM
Lind Global Fund II LP (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
Seelos Therapeutics (Subject)
Form SC 13G/A
11/05/2024
12:46 PM
AdvisorShares Trust (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
Seelos Therapeutics (Subject)
Form SC 13G
10/24/2024
3:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
10/24/2024
3:10 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
8:15 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
5:07 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
09/26/2024
3:10 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
7:53 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
5:09 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/24/2024
3:05 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
8:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2024
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
08/16/2024
3:02 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/30/2024
3:23 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/12/2024
8:15 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
06/25/2024
3:23 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B3
05/31/2024
3:30 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
05/20/2024
3:16 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B5
05/16/2024
8:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
10:45 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
7:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:30 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-K/A
03/28/2024
7:00 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2024
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
03/06/2024
4:32 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-1/A
03/06/2024
3:50 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2024
4:39 PM
Golembiewski Michael Joseph (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
4:26 PM
Lind Global Fund II LP (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
Seelos Therapeutics (Subject)
Form SC 13G
02/02/2024
5:04 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/30/2024
3:01 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:05 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 424B5
01/22/2024
7:05 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
8:47 PM
Golembiewski Michael Joseph (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
8:47 PM
Mehra Raj (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:16 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

01/08/2024
8:45 PM
O'Connor Daniel J. (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:45 PM
Lian Brian (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:45 PM
DALESANDRO MARGARET (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:46 PM
Pascoe Richard W (Reporting)
SEELOS THERAPEUTICS, INC. (Issuer)
Seelos Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:10 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/27/2023
11:15 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form EFFECT
12/22/2023
3:01 PM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
12/22/2023
7:10 AM
SEELOS THERAPEUTICS, INC. (Filer)
Seelos Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SEEL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners